Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

The Lancet Won’t Retract Anti-Israel Letter on Gaza Despite Authors’ Radical Ties

The Lancet will not retract a letter slamming Israeli policy in Gaza in light of evidence tying two of the authors to support for white supremacist David Duke.

The British medical journal’s editor, Dr. Richard Horton, dismissed evidence that two of the five authors of “An open letter for the people of Gaza,” published in the August issue, had distributed a video by Duke, according to The Telegraph. Horton called the revelations “utterly irrelevant” and “a smear campaign.”

The letter described Israel’s Gaza campaign as “a massacre” and “a ruthless assault.”

NGO Monitor, a media watchdog, unearthed emails of Dr. Paola Manduca, a geneticist at the University of Genoa, and Dr. Swee Ang, an orthopedic surgeon, forwarding a video titled “CNN, Goldman Sachs, and the Zio Matrix” in which Duke accuses Jewish banking, media and political figures of conspiring to create “an unholy tribal alliance.” Duke has had ties to the Ku Klux Klan and neo-Nazi groups.

In her email, Ang writes, “This is shocking video please watch. This is not about Palestine — it is about all of us!”

Manduca also forwarded an article suggesting that a Jewish conspiracy may have been behind the Boston Marathon bombings.

In response to questions from the Telegraph, Manduca denied being anti-Semitic, but added, “I legitimately use my right of freedom of opinion and do not agree or value the politics of the government of Israel, nor of many others, including Jews in and out of Israel.”

Ang, in turn, told the Telegraph, “I didn’t know who David Duke was, or that he was connected to the Ku Klux Klan. I am concerned that if there is any truth in the video, that Jews control the media, politics and banking, what on earth is going on? I was worried.”

Lancet’s refusal to withdraw the letter in light of the new information has drawn condemnations from respected figures in the British medical establishment.

Mark Pepys, director of the Wolfson Drug Discovery Unit at University College London, wrote that “Horton’s behavior in this case is consistent with his longstanding and wholly inappropriate use of The Lancet as a vehicle for his own extreme political views,” according to the Telegraph.

Pepys added, “It has greatly detracted from the former high standing of the journal.”

Horton dismissed the criticism.

“I don’t honestly see what all this has to do with the Gaza letter,” he told the Telegraph. “I have no plans to retract the letter, and I would not retract the letter even if it was found to be substantiated.”

A message from our Publisher & CEO Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $325,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.